Canine immune-mediated haemolytic anaemia part 1: presentation, diagnosis and treatment
Rachel Palin
Thursday, September 2, 2021
Immune-mediated haemolytic anaemia (IMHA) is one of the most prevalent immune-mediated diseases in canines, and it carries a guarded prognosis because of the substantial rates of morbidity and mortality. Comprehensive supportive nursing care is critical in patients with IMHA.This first article discusses the presentation, diagnosis and treatment options in canine IMHA patients. A subsequent article will follow focusing on how the condition, and its treatment options, impact the supportive nursing requirements that should therefore be considered, as well as possible complications that may arise. Through good nursing care, as well as a knowledge and understanding of the requirements of these patients, RVNs have a vital role in influencing these patients' outcomes.
Subscribe to get full access to The Veterinary Nurse
Thank you for vising The Veterinary nurse and reading our archive of expert clinical content. If you would like to read more from the leading peer-reviewed journal for veterinary nurses, you can start your subscription today for just £26.
Subscribing will enable you to:
- Stay up-to-date with current thinking and best practice in veterinary medicine
- Enhance your knowledge and understanding of all key clinical topics
- Achieve the mandatory requirement of 45 hours' documented CPD over a three-year period